EP 3490534 A1 20190605 - ORAL COMPOSITION OF ANTI-TNF-ALPHA ANTIBODIES
Title (en)
ORAL COMPOSITION OF ANTI-TNF-ALPHA ANTIBODIES
Title (de)
ORALE ZUSAMMENSETZUNG VON ANTI-TNF-ALPHA-ANTIKÖRPERN
Title (fr)
COMPOSITION ORALE D'ANTICORPS ANTI-TNF ALPHA
Publication
Application
Priority
- FR 1657442 A 20160729
- EP 2017068918 W 20170726
Abstract (en)
[origin: WO2018019900A1] The present application relates to a pharmaceutical composition for oral administration, comprising a monoclonal anti-tumor necrosis factor alpha antibody (TNFα) and at least one or more pharmaceutically acceptable excipients selected from the group comprising: a carboxymethyl-dextran, a chitosan, a cyclodextrin, or a combination of same, as well as the use of said composition in the treatment of inflammatory diseases or autoimmune diseases.
IPC 8 full level
A61K 9/16 (2006.01); A61K 9/19 (2006.01); A61K 39/395 (2006.01)
CPC (source: EP US)
A61K 9/1652 (2013.01 - EP US); A61K 9/19 (2013.01 - EP US); A61K 39/39591 (2013.01 - EP US); A61P 29/00 (2017.12 - EP US); A61P 37/06 (2017.12 - EP US); C07K 16/24 (2013.01 - EP US); C07K 16/241 (2013.01 - US)
Citation (search report)
See references of WO 2018019900A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2018019900 A1 20180201; CA 3031033 A1 20180201; EP 3490534 A1 20190605; FR 3054444 A1 20180202; US 2019270801 A1 20190905
DOCDB simple family (application)
EP 2017068918 W 20170726; CA 3031033 A 20170726; EP 17749664 A 20170726; FR 1657442 A 20160729; US 201716320297 A 20170726